Displaying items by tag: center for clinical and translational science

These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.
New technologies are filling in gaps in the human genome and opening major areas for discovery. UAB researchers explain the pros and cons and how they are using long reads at UAB.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
CABG is a commonly performed, lifesaving surgery for patients with heart attacks and severe disease of the heart’s blood vessels. Avoiding a surgery like CABG due to fears of COVID-19 has “drastic implications.”
The train-the-trainers approach to moving scientific discovery to the marketplace adds 13 more training sites.
UAB’s CCTS joins a nationwide collaboration creating a secure, central database of electronic health records from coronavirus patients.
The results will demonstrate where the novel coronavirus has spread undetected in the United States and provide insights into the types of populations that are most affected.
The complement system is part of the body’s immune system to fight pathogens and remove cell debris. Its role in two autoimmune diseases and a mental disorder is a surprise.

Chaplin has been chosen as a distinguished fellow by the American Association of Immunologists for his contributions to the field of immunology.

Page 1 of 4